Imatinib
- Active ingredient / generic name
- imatinib
- ATC code
- L01EA01
- Administration route
- Oral
Source-based interaction record
Imatinib + Nilotinib
Imatinib + Nilotinib: published drug interaction record, medicine facts and reference links. Generic / active ingredient: imatinib + nilotinib.
Free preview
Essential record information
Free record overview for Imatinib + Nilotinib. Review the medicine identities and available reference links below; detailed interaction information is in the access section.
Nilotinib
- Active ingredient / generic name
- nilotinib
- ATC code
- L01EA03
- Administration route
- Oral
- Record type
- Published interaction record
- Source record version
- DailyMed TASIGNA SPL v42; effective 2025-12-16; checked 2026-11-04; 12.3
Source checked:
A source check is not an independent clinical review.
Examples selected from real records
Selected free interaction examples
These examples concern other medicine pairs involving the medicines above. They do not assess the main pair on this page.
Published related records: 104. The selection below does not represent the complete list.
Minor
Imatinib + Lopresor 100 mg
Recorded classification; this selection is not a full list or a conclusion that use is safe.
dailymed.nlm.nih.gov (opens in a new tab)Source checked:
View record Minor
Beloc-Zok 50 mg + Imatinib
Recorded classification; this selection is not a full list or a conclusion that use is safe.
dailymed.nlm.nih.gov (opens in a new tab)Source checked:
View record Minor
Beloc ZOK 25 mg + Imatinib
Recorded classification; this selection is not a full list or a conclusion that use is safe.
dailymed.nlm.nih.gov (opens in a new tab)Source checked:
View record Important information and detailed context
Unlock important interaction details
The basic information is available above. Details such as explanations of moderate or severe interaction records, mechanisms and clinical context are available through paid access to the relevant record or your membership allowance.
The related record group also includes interactions classified as moderate or severe. Each record’s access right applies to its own details.
- Interaction level and explanation
- Interaction mechanism
- Clinical context and precautions
Already have an account? Sign in
Monthly memberships renew automatically; there is no trial period. Taxes and the final total appear in checkout.
A verified account is required. Turkish and English versions of the same resource share one access right.
This information is not personal treatment advice. Discuss treatment decisions with your doctor or pharmacist.